George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

21 Mar 2017 07:00

RNS Number : 0059A
ABCAM Plc
21 March 2017
 

 

For immediate release

21 March 2017

ABCAM PLC

("Abcam" or the "Company")

Director/PDMR Shareholding Notification

Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, has been notified of the following dealings in Abcam's shares by certain Directors of the Company as follows:

 

· Murray Hennessy, Chairman, purchased 5,922 ordinary shares of 0.2 pence each in the Company ("Shares") at a price of £8.470863 per share on Monday 20 March 2017.

· Alan Hirzel, Chief Executive Officer, purchased 6,000 Shares at a price of £8.395 per share on Friday 17 March 2017.

· Gavin Wood, Chief Financial Officer, purchased 5,815 Shares at a price of £8.4263 per share on Friday 17 March 2017.

· Mara Aspinall, Non-Executive Director, purchased 2,370 Shares at a price of £8.488462 per share on Monday 20 March 2017.

 

The notifications for Mr Hennessy, Mr Hirzel, Mr Wood and Ms Aspinall can be found below. This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 

##Ends##

 

For further information, please contact:

Abcam

+ 44 (0) 1223 696 000

Suzanne Smith, Company Secretary

 

J.P.Morgan Cazenove - Nominated Advisor & Corporate Broker

+ 44 (0) 20 7742 4000

James Mitford / Christopher Cargill

FTI Consulting

+ 44 (0) 20 3727 1000

Ben Atwell / Brett Pollard / Natalie Garland-Collins

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mr Murray Hennessy

2

Reason for the notification

a)

Position/status

Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

213800B9N83DSNT33F79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

£8.470863

5,922

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

5,922

£8.470863

£50,164.45

f)

Date of the transaction

20 March 2017

g)

Place of the transaction

London Stock Exchange, AIM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Alan Hirzel

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

213800B9N83DSNT33F79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

£8.39

6,000

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

6,000

£8.39

£50,340

f)

Date of the transaction

17 March 2017

g)

Place of the transaction

London Stock Exchange, AIM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mr Gavin Wood

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

213800B9N83DSNT33F79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

£8.4263

5,815

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

5,815

£8.4263

£48,999

 

f)

Date of the transaction

17 March 2017

g)

Place of the transaction

London Stock Exchange, AIM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mara Aspinall

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

213800B9N83DSNT33F79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.2 pence each

 

 

 

GB00B6774699

b)

Nature of the transaction

Purchase of shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

£8.488462

2,370

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

2,370

£8.488462

£20,117.65

f)

Date of the transaction

20 March 2017

g)

Place of the transaction

London Stock Exchange, AIM

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHDBLFLDXFEBBE
Date   Source Headline
1st Oct 20204:41 pmRNSTotal Voting Rights
25th Sep 20201:33 pmRNSDirector/PDMR Shareholding
18th Sep 20202:19 pmRNSBlock listing Interim Review
18th Sep 20207:54 amRNSDirector/PDMR Shareholding
14th Sep 20207:00 amRNSFull Year Results 2020
11th Sep 202010:34 amRNSNotice of Results
1st Sep 20207:52 amRNSTotal Voting Rights
4th Aug 202012:57 pmRNSTotal Voting Rights
23rd Jul 20207:00 amRNSChange of Adviser
23rd Jul 20207:00 amRNSFull Year Trading Update
2nd Jul 202010:11 amRNSTotal Voting Rights
16th Jun 202012:00 pmRNSDirectorate Change
1st Jun 20209:29 amRNSTotal Voting Rights
11th May 202011:00 amRNSStatement re Update on 2019 AGM Resolution Vote
1st May 202012:24 pmRNSTotal Voting Rights
22nd Apr 202010:11 amRNSHolding(s) in Company
21st Apr 20207:26 amRNSDirector/PDMR Shareholding
20th Apr 202010:19 amRNSHolding(s) in Company
20th Apr 20207:00 amRNSCOVID-19 Update
14th Apr 202010:07 amRNSHolding(s) in Company
9th Apr 20205:33 pmRNSIssue of Shares
2nd Apr 20209:50 amRNSTotal Voting Rights
27th Mar 20203:37 pmRNSHolding(s) in Company
9th Mar 20207:00 amRNSInterim results for 6 months ended 31 Dec 2019
4th Mar 20207:00 amRNSAcquisition of Marker Gene Technologies
2nd Mar 20203:43 pmRNSTotal Voting Rights
2nd Mar 20208:00 amRNSBlock listing Interim Review
4th Feb 202010:49 amRNSTotal Voting Rights
30th Jan 20207:00 amRNSAbcam expands cell engineering capabilities
28th Jan 20202:31 pmRNSHolding(s) in Company
28th Jan 20202:29 pmRNSDirector/PDMR Shareholding
14th Jan 20207:00 amRNSAppointment of Chief Financial Officer
10th Jan 20207:00 amRNSHalf Year Trading Update
2nd Jan 20209:45 amRNSTotal Voting Rights
2nd Jan 20207:00 amRNSTransaction complete between Abcam and Expedeon
19th Dec 201910:05 amRNSHolding(s) in Company
4th Dec 20193:37 pmRNSHolding(s) in Company
2nd Dec 20193:25 pmRNSDirector/PDMR Shareholding
2nd Dec 20199:30 amRNSTotal Voting Rights
21st Nov 201911:42 amRNSHolding(s) in Company
14th Nov 20197:00 amRNSAbcam Capital Markets Event
13th Nov 20194:45 pmRNSResult of AGM
11th Nov 20197:00 amRNSAbcam to acquire proteomics & immunology business
6th Nov 20199:06 amRNSDirector/PDMR Shareholding
1st Nov 201910:55 amRNSTotal Voting Rights
2nd Oct 20194:28 pmRNSHolding(s) in Company
2nd Oct 20191:49 pmRNSDirector/PDMR Shareholding
1st Oct 20192:22 pmRNSTotal Voting Rights
30th Sep 20191:35 pmRNSAnnual Financial Report
26th Sep 20192:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.